D. Dunbar Ivy mainly focuses on Pulmonary hypertension, Internal medicine, Anesthesia, Vascular resistance and Cardiology. His Pulmonary hypertension study combines topics in areas such as Respiratory disease, Surgery, Pulmonary artery, Bosentan and Hemodynamics. His Internal medicine research includes themes of Pediatric population, Fetus, Endocrinology and Genetic linkage.
His Anesthesia research is multidisciplinary, incorporating elements of Sildenafil and Nitric oxide. His studies in Vascular resistance integrate themes in fields like Hypoxic pulmonary vasoconstriction, Pediatrics, Heart failure and Vasodilation. His Cardiology research incorporates elements of Incidence and Autosomal dominant polycystic kidney disease.
His primary scientific interests are in Internal medicine, Pulmonary hypertension, Cardiology, Pulmonary artery and Vascular resistance. The concepts of his Internal medicine study are interwoven with issues in Fetus, Endocrinology and Surgery. D. Dunbar Ivy combines subjects such as Respiratory disease, Lung, Anesthesia, Intensive care medicine and Pediatrics with his study of Pulmonary hypertension.
His Anesthesia research incorporates themes from Treprostinil and Nitric oxide. His Cardiology study frequently links to other fields, such as Magnetic resonance imaging. His study looks at the intersection of Pulmonary artery and topics like Bosentan with Pharmacokinetics.
D. Dunbar Ivy mainly investigates Internal medicine, Pulmonary hypertension, Cardiology, Hemodynamics and Magnetic resonance imaging. As a member of one scientific family, D. Dunbar Ivy mostly works in the field of Internal medicine, focusing on Gastroenterology and, on occasion, Disease severity. His Pulmonary hypertension research is multidisciplinary, incorporating perspectives in Intensive care medicine, Vascular resistance, Pulmonary artery, Lung and Heart disease.
His Pulmonary artery study frequently involves adjacent topics like Bosentan. Cardiology and Diastole are commonly linked in his work. His work carried out in the field of Hemodynamics brings together such families of science as Flow and Cardiac magnetic resonance.
Internal medicine, Cardiology, Pulmonary hypertension, Afterload and Intensive care medicine are his primary areas of study. In Internal medicine, D. Dunbar Ivy works on issues like Magnetic resonance imaging, which are connected to Computed tomography. His Pulmonary hypertension research integrates issues from Cardiac catheterization, Respiratory failure, Vascular resistance, Pathophysiology and Lung.
The study incorporates disciplines such as Interquartile range, Heart disease and Fisher's exact test in addition to Vascular resistance. His study in Intensive care medicine is interdisciplinary in nature, drawing from both Observational study, Clinical trial, Long term survival, Treprostinil and Disease. His Hemodynamics research is multidisciplinary, relying on both Contractile response and Severity of illness.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Pediatric Pulmonary Hypertension: Guidelines From the American Heart Association and American Thoracic Society
Steven H. Abman;Georg Hansmann;Stephen L. Archer;D. Dunbar Ivy.
Hypoplastic Left Heart Syndrome : Current Considerations and Expectations
Jeffrey A. Feinstein;D. Woodrow Benson;Anne M. Dubin;Meryl S. Cohen.
Journal of the American College of Cardiology (2012)
Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension.
Robyn J. Barst;Robyn J. Barst;Robyn J. Barst;Dunbar Ivy;Dunbar Ivy;Dunbar Ivy;Jasper Dingemanse;Jasper Dingemanse;Jasper Dingemanse;Allison Widlitz;Allison Widlitz;Allison Widlitz.
Clinical Pharmacology & Therapeutics (2003)
Pediatric Pulmonary Hypertension
D. Dunbar Ivy;Steven H. Abman;Robyn J. Barst;Rolf M.F. Berger.
Journal of the American College of Cardiology (2013)
Clinical features of paediatric pulmonary hypertension: a registry study
Rudolphus Berger;Maurice Beghetti;Tilman Humpl;Gary E. Raskob.
The Lancet (2012)
Attenuation of acute hypoxic pulmonary vasoconstriction and hypoxic pulmonary hypertension in mice by inhibition of Rho-kinase.
Karen A. Fagan;Masahiko Oka;Natalie R. Bauer;Sarah A. Gebb.
American Journal of Physiology-lung Cellular and Molecular Physiology (2004)
Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide
John P. Kinsella;Steven R. Neish;D. Dunbar Ivy;Elizabeth Shaffer.
The Journal of Pediatrics (1993)
A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of Oral Sildenafil Citrate in Treatment-Naive Children With Pulmonary Arterial Hypertension
Robyn J. Barst;D. Dunbar Ivy;Guillermo Gaitan;Andras Szatmari.
Effects of long-term bosentan in children with pulmonary arterial hypertension.
Erika Berman Rosenzweig;D. Dunbar Ivy;Allison Widlitz;Aimee Doran.
Journal of the American College of Cardiology (2005)
Survival in Childhood Pulmonary Arterial Hypertension Insights From the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management
Robyn J. Barst;Michael D. McGoon;C. Gregory Elliott;Aimee J. Foreman.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: